NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$12,871
-2.78%
Shares
Shares Volume: 7,355 Shares
Average Share Price: $1.75
INSIDER
Zalevsky Jonathan
Chief R&D Officer (Officer)
reported on May 20 2024
traded on May 17 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 257,670 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $7,823.91 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $14,072.68 |
| COMPANY PREVIOUS TRADES |